Cargando…
HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis
Although epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) show efficacy in lung adenocarcinoma (LUAD) patients, TKI resistance inevitably develops, limiting long-term results. Thus, there is an urgent need to address drug resistance in LUAD. Long non-coding RNA (lncRNA) HIF1A-AS2 c...
Autores principales: | Si, Jiahui, Ma, Yuanyuan, Lv, Chao, Hong, Yang, Tan, Hongyu, Yang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517096/ https://www.ncbi.nlm.nih.gov/pubmed/34703647 http://dx.doi.org/10.1016/j.omtn.2021.09.003 |
Ejemplares similares
-
circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis
por: Hong, Yang, et al.
Publicado: (2022) -
miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an In vitro sepsis model
por: Pfeiffer, Dagmar, et al.
Publicado: (2017) -
STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b
por: Walker, Sarah R., et al.
Publicado: (2014) -
Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer
por: Yan, Meina, et al.
Publicado: (2021) -
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017)